|
|
|
|
Caterpillar joins backers of power plant project
Backers of the planned experimental clean-coal power plant called FutureGen say the public-private venture envisioned for eastern Illinois has landed another corporate partner.Pat Quinn and Sen. Dick Durbin say Peoria-based Caterpillar is joining the...
|
|
|
Cancer-Treatment Isotope Supply to Increase from Landmark Deal Reached by GE Hitachi Nuclear Energy and Exelon
Seeking to address a growing demand for the domestic and global supply of cobalt-60, a radioisotope used for treating cancer and other biomedical applications, GE Hitachi Nuclear Energy (GEH) and Exelon Generation Company have agreed to a landmark deal to...
|
|
|
Exelon says it will join Ill.'s FutureGen Alliance
One of the nation's largest power generators plans to join the FutureGen Alliance, an organization developing an experimental clean-coal power plant in eastern Illinois.Chicago-based Exelon Corp. says it wants to help build the plant near Mattoon.
|
|
|
How to Make Billions of Dollars Without Really Trying
Recs 1 //Create your sharelet with desired properties and set button element to false object //Tie customized button to This button functionality.element Disney Buys Marvel! David Gardner called it! Hes up 1,334%! See what Davids recommending that you...
|
|
|
How to Make Billions of Dollars Without Really Trying
There are few truly untapped drug markets out there.Lupus hasn't seen a new drug developed specifically for it in the last 50 years, although Human Genome Sciences and GlaxoSmithKline are close to getting one approved. Merck (NYSE: MRK), Vertex...
|
|
|
How to Make Billions of Dollars Without Really Trying
Recs 0 //Create your sharelet with desired properties and set button element to false object //Tie customized button to This button functionality.element Disney Buys Marvel! David Gardner called it! Hes up 1,334%! See what Davids recommending that you...
|
|
|
Suite Talk, Jan. 28, 2010
Tags: Lobbyists , Suite Talk , Boeing , By BECCA MILFELD & ANNE MARSON | 1/28/10 4:44 AM EST Text Size - + reset Photo: Digg/Buzz It Up POLITICO 44 The Politico 44 / Click Story Widget Requires Adobe Flash Player.Young to ASGK Jason Young is the new...
|
|
|
IL ASGK Names Young
BC-IL-ASGK-Names-Young To: POLITICAL EDITORS Contact: Chris Lisi, +1-202-549-0696, chris@lisicommunications.com, for ASGK Public Strategies Chicago-Based Public Affairs Firm Expands In Key Market CHICAGO, Jan.26 /PRNewswire-USNewswire/ -- ASGK Public...
|
|
|
Novartis held the line on sales and marketing spend in 2009
Novartis' US sales reorg seems to have paid off in 2009 as the company held the line on sales and marketing expenses despite a passel of global launches.The company said in its 2009 results that sales and marketing spend for its pharmaceutical division fell...
|
|
|
Top 10 Hot stocks to buy right now in 2010!
Exelon ( EXC , news : 47.11 -1.96% )- Exelon Corporation is one of the nations largest electric utilities with approximately $19 billion in annual revenues.We distribute electricity to approximately 5.4 million customers in Illinois (ComEd) and...
|
|
|
GE Hitachi Nuclear Energy, Exelon Enter Into Cancer Research Agreement
GE Hitachi Nuclear Energy (GEH) and Exelon have entered into an agreement to deploy GEHs isotope generation technology for the domestic and global supply of cobalt-60, a radioisotope used as a radiation source for treating cancer and other biomedical...
|
|
|
Cancer-Treatment Isotope Supply to Increase from Landmark Deal Reached by GE Hitachi Nuclear Energy and Exelon
- Seeking to address a growing demand for the domestic and global supply of cobalt-60, a radioisotope used for treating cancer and other biomedical applications, GE Hitachi Nuclear Energy (GEH) and Exelon Generation Company have agreed to a landmark deal...
|
|
|
GEH, Exelon Generation agree to a landmark deal to deploy GEHs isotope generation technology
Seeking to address a growing demand for the domestic and global supply of cobalt-60, a radioisotope used for treating cancer and other biomedical applications, GE Hitachi Nuclear Energy (GEH) and Exelon Generation Company have agreed to a landmark deal to...
|
|
|
Cancer-Treatment Isotope Supply to Increase from Landmark Deal Reached by GE Hitachi Nuclear Energy and Exelon
WILMINGTON, N.C.--(BUSINESS WIRE)-- Seeking to address a growing demand for the domestic and global supply of cobalt-60, a radioisotope used for treating cancer and other biomedical applications, GE Hitachi Nuclear Energy (GEH) and Exelon Generation...
|
|
|
Cancer-Treatment Isotope Supply to Increase from Landmark Deal Reached by GE Hitachi Nuclear Energy and Exelon
Seeking to address a growing demand for the domestic and global supply of cobalt-60, a radioisotope used for treating cancer and other biomedical applications, GE Hitachi Nuclear Energy (GEH) and Exelon Generation Company have agreed to a landmark deal to...
|
|
|
Cancer-Treatment Isotope Supply to Increase from Landmark Deal Reached by GE Hitachi Nuclear Energy and Exelon Generation Company
WILMINGTON, N.C.Seeking to address a growing demand for the domestic and global supply of cobalt-60, a radioisotope used for treating cancer and other biomedical applications, GE Hitachi Nuclear Energy (GEH) and Exelon Generation Company have agreed to...
|
|
|
Cancer-Treatment Isotope Supply to Increase from Landmark Deal Reached by GE Hitachi Nuclear Energy and Exelon Generation Company
WILMINGTON, N.C.--(BUSINESS WIRE)--Seeking to address a growing demand for the domestic and global supply of cobalt-60, a radioisotope used for treating cancer and other biomedical applications, GE Hitachi Nuclear Energy (GEH) and Exelon Generation...
|
|
|
Cancer-Treatment Isotope Supply to Increase from Landmark Deal Reached by GE Hitachi Nuclear Energy and Exelon
Seeking to address a growing demand for the domestic and global supply of cobalt-60, a radioisotope used for treating cancer and other biomedical applications, GE Hitachi Nuclear Energy (GEH) and Exelon Generation Company have agreed to a landmark deal to...
|
|
|
Cancer-Treatment Isotope Supply to Increase from Landmark Deal Reached by GE Hitachi Nuclear Energy and Exelon
WILMINGTON, N.C.--(BUSINESS WIRE)--Seeking to address a growing demand for the domestic and global supply of cobalt-60, a radioisotope used for treating cancer and other biomedical applications, GE Hitachi Nuclear Energy (GEH) and Exelon Generation...
|
|
|
Cancer-Treatment Isotope Supply to Increase from Landmark Deal Reached by GE Hitachi Nuclear Energy and Exelon
WILMINGTON, N.C.--(EON: Enhanced Online News)--Seeking to address a growing demand for the domestic and global supply of cobalt-60, a radioisotope used for treating cancer and other biomedical applications, GE Hitachi Nuclear Energy (GEH) and Exelon...
|
|
|
Cancer-Treatment Isotope Supply to Increase from Landmark Deal Reached by GE Hitachi Nuclear Energy and Exelon Generation Company
More News related to GE More News related to Press Releases WILMINGTON, N.C.--(BUSINESS WIRE)-- Seeking to address a growing demand for the domestic and global supply of cobalt-60, a radioisotope used for treating cancer and other biomedical applications, GE...
|
|
|
Cancer-Treatment Isotope Supply to Increase from Landmark Deal Reached by GE Hitachi Nuclear Energy and Exelon
WILMINGTON, N.C.--(BUSINESS WIRE)--Seeking to address a growing demand for the domestic and global supply of cobalt-60, a radioisotope used for treating cancer and other biomedical applications, GE Hitachi Nuclear Energy (GEH) and Exelon Generation...
|
|
|
Cancer-Treatment Isotope Supply to Increase from Landmark Deal Reached by GE Hitachi Nuclear Energy and Exelon Generation Company
Seeking to address a growing demand for the domestic and global supply of cobalt-60, a radioisotope used for treating cancer and other biomedical applications, GE Hitachi Nuclear Energy (GEH) and Exelon Generation Company have agreed to a landmark deal to...
|
|
|
Cancer-Treatment Isotope Supply to Increase from Landmark Deal Reached by GE Hitachi Nuclear Energy and Exelon Generatio
WILMINGTON, N.C.- (BUSINESS WIRE) - Seeking to address a growing demand for the domestic and global supply of cobalt-60, a radioisotope used for treating cancer and other biomedical applications, GE Hitachi Nuclear Energy (GEH) and Exelon Generation...
|
|
|
Cancer-Treatment Isotope Supply to Increase from Landmark Deal Reached by GE Hitachi Nuclear Energy and
Seeking to address a growing demand for the domestic and global supply of cobalt-60, a radioisotope used for treating cancer and other biomedical applications, GE Hitachi Nuclear Energy (GEH) and Exelon Generation Company have agreed to a landmark deal to...
|
